Hexapeptide-9
Cosmetic ingredientCosmetic signal peptide
Also known as: Collaxyl, Apepbiosix-5, Gly-Pro-Gln-Gly-Pro-Gln, Hexapeptide 9, Hexapeptide-9 (acetate), Collaxyl IS, Hexapeptide-9?
Very thin human evidence
- Regulatory standing. Cosmetic ingredient, not regulated as a drug
- Animal / preclinical only. Evidence is largely animal or in-vitro
- No registered human trials. Nothing registered on ClinicalTrials.gov
- 1 cited source. Includes primary / regulatory sources
Computed with the same four public criteria as every profile. The human-evidence grade on an indexed profile is set automatically and may change when it is hand-reviewed. It is not a safety score, not a purity rating, and not medical advice, and not a claim that this compound treats, cures, or prevents any condition.
What it is
Hexapeptide-9, sold under the trade name Collaxyl, is a short synthetic peptide used as an ingredient in cosmetic skin care products. Its sequence is modeled on fragments of collagen, and it is thought to act as a signaling peptide that may encourage skin cells to produce structural proteins such as collagen. It is regulated as a cosmetic ingredient, not as a drug.
What the evidence shows
There are no registered human clinical trials and only a small number of published papers, with most support coming from lab studies and manufacturer-reported data. Any effect on skin appearance in humans has not been established by independent, rigorous research.
Key facts
Registered human trials
Live from ClinicalTrials.gov, refreshed daily.
Published literature
Live from Europe PMC. This is how much has been published, not how much is proven in humans.
Two alternative conformations of S-adenosyl-L-homocysteine bound to Escherichia coli DNA adenine methyltransferase and the implication of conformational changes in regulating the catalytic cycle.
Novel Cyclized Hexapeptide-9 Outperforms Retinol Against Skin Aging: A Randomized, Double-Blinded, Active- and Vehicle-Controlled Clinical Trial.
A framework for the safety evaluation of peptides in cosmetics.
Pioneering ionic liquids in neuro-soothing: Enhanced transdermal delivery of collagen peptides and their synergistic anti-aging functions.
Sources
- PubChem compound record (CID 16129319)
- Registered trials on ClinicalTrials.gov
- Published papers on Europe PMC
Risks, side effects and study doses are only published on hand-reviewed profiles. Want this one reviewed, or spotted something wrong? Tell us.